Table III.
Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|
Characteristic | HR (95% CI) | P-value | HR (95% CI) | P-value |
Age | 0.81 (0.45–1.48) | 0.387 | ||
Tumor size | 1.61 (0.88–2.93) | 0.119 | ||
Histological grade | 2.99 (1.20–7.45) | 0.018 | 4.46 (1.43–13.94) | 0.010 |
Lymph node status | 2.85 (1.50–5.38) | 0.001 | 2.13 (1.07–4.56) | 0.045 |
ER status | 0.73 (0.36–1.47) | 0.376 | ||
HER-2 status | 1.17 (0.59–2.32) | 0.654 | ||
Ki-67 | 3.52 (1.23–10.12) | 0.019 | 4.61 (1.26–16.95) | 0.021 |
POLD1 | 3.14 (1.67–5.91) | <0.001 | 2.14 (0.99–4.68) | 0.048 |
DFS, disease-free survival; ER, estrogen receptor; HER-2, human epidermal receptor-2; POLD1, polymerase δ catalytic subunit gene.